BFC Planning’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
BFC Planning's PCVX Position: Q3 2026 in Review
BFC Planning increased its Vaxcyte (PCVX) stake by 75% in Q3 2026, buying an estimated $874 and bringing the position to 35 shares worth $1.99K. The position accounts for ﹤0.01% of the portfolio, ranked #3008.
BFC Planning first reported a position in PCVX in Q3 2024 and has held it in 9 quarters since. 259 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- BFC Planning held 35 shares of Vaxcyte worth $1.99K as of Q3 2026.
- BFC Planning bought 15 Vaxcyte shares in Q3 2026, an estimated $874.
- Vaxcyte made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3008 holding.
- BFC Planning first reported a position in Vaxcyte in Q3 2024 and has held it in 9 quarters since.
- 259 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.